Sun Recalls One Lot of Nimodipine on Crystallization Concerns

Washington Drug Letter
A A
Sun Pharmaceutical is recalling one lot of its 30-mg nimodipine after a customer complaint about possible crystallization of the solution inside the capsule.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00